These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 15538936)

  • 1. Greater use of insulin by southern European compared with Anglo-Celt patients with type 2 diabetes: the Fremantle Diabetes Study.
    Clifford RM; Davis WA; Cull CA; Bruce DG; Batty KT; Davis TM
    Eur J Endocrinol; 2004 Nov; 151(5):579-86. PubMed ID: 15538936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in characteristics and management of Asian and Anglo-Celts with type 2 diabetes over a 15-year period in an urban Australian community: The Fremantle Diabetes Study.
    Tan ED; Davis WA; Davis TM
    J Diabetes; 2016 Jan; 8(1):139-47. PubMed ID: 25581285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoprotein E genotype and mortality in Southern European and Anglo-Celt patients with type 2 diabetes: the Fremantle Diabetes Study.
    Davis WA; Chin E; Jee A; Martins J; Bruce DG; Beilby J; Davis TM
    Eur J Endocrinol; 2010 Oct; 163(4):559-64. PubMed ID: 20693183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuing disparities in cardiovascular risk factors and complications between aboriginal and Anglo-Celt Australians with type 2 diabetes: the Fremantle Diabetes Study.
    Davis TM; Hunt K; McAullay D; Chubb SA; Sillars BA; Bruce DG; Davis WA
    Diabetes Care; 2012 Oct; 35(10):2005-11. PubMed ID: 22815295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics and prognosis of Asian patients with type 2 diabetes from a multi-racial Australian community: the Fremantle Diabetes Study.
    Tan ED; Davis WA; Davis TM
    Intern Med J; 2013 Oct; 43(10):1125-32. PubMed ID: 23869413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is self-monitoring of blood glucose appropriate for all type 2 diabetic patients? The Fremantle Diabetes Study.
    Davis WA; Bruce DG; Davis TM
    Diabetes Care; 2006 Aug; 29(8):1764-70. PubMed ID: 16873777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of insulin therapy on quality of life in Type 2 diabetes mellitus: The Fremantle Diabetes Study.
    Davis TM; Clifford RM; Davis WA;
    Diabetes Res Clin Pract; 2001 Apr; 52(1):63-71. PubMed ID: 11182217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advancing therapy in type 2 diabetes mellitus with early, comprehensive progression from oral agents to insulin therapy.
    Vinik A
    Clin Ther; 2007; 29 Spec No():1236-53. PubMed ID: 18046925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determinants of diabetes-attributable non-blood glucose-lowering medication costs in type 2 diabetes: the Fremantle Diabetes Study.
    Davis WA; Knuiman MW; Hendrie D; Davis TM
    Diabetes Care; 2005 Feb; 28(2):329-36. PubMed ID: 15677788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe hypoglycemia is associated with antidiabetic oral treatment compared with insulin analogs in nursing home patients with type 2 diabetes and dementia: results from the DIMORA study.
    Abbatecola AM; Bo M; Barbagallo M; Incalzi RA; Pilotto A; Bellelli G; Maggi S; Paolisso G;
    J Am Med Dir Assoc; 2015 Apr; 16(4):349.e7-12. PubMed ID: 25669671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased complications in noninsulin-dependent diabetic patients treated with insulin versus oral hypoglycemic agents: a population study.
    Savage S; Estacio RO; Jeffers B; Schrier RW
    Proc Assoc Am Physicians; 1997 Mar; 109(2):181-9. PubMed ID: 9069587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. U.K. prospective diabetes study 16. Overview of 6 years' therapy of type II diabetes: a progressive disease. U.K. Prospective Diabetes Study Group.
    Diabetes; 1995 Nov; 44(11):1249-58. PubMed ID: 7589820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type II diabetes mellitus.
    Edelman SV
    Adv Intern Med; 1998; 43():449-500. PubMed ID: 9506190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glimepiride. A review of its use in the management of type 2 diabetes mellitus.
    Langtry HD; Balfour JA
    Drugs; 1998 Apr; 55(4):563-84. PubMed ID: 9561345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of insulin sensitivity, beta-cell function and glycaemic control on initiation of second-line glucose-lowering treatment in newly diagnosed type 2 diabetes.
    Rathmann W; Strassburger K; Bongaerts B; Bobrov P; Kuss O; Müssig K; Markgraf DF; Szendroedi J; Herder C; Roden M;
    Diabetes Obes Metab; 2017 Jun; 19(6):866-873. PubMed ID: 28127851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strategies for glucose control in a study population with diabetes, renal disease and anemia (Treat study).
    Weinrauch LA; D'Elia JA; Finn P; Lewis EF; Desai AS; Claggett BL; Cooper ME; McGill JB
    Diabetes Res Clin Pract; 2016 Mar; 113():143-51. PubMed ID: 26830074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral antidiabetic agents: current role in type 2 diabetes mellitus.
    Krentz AJ; Bailey CJ
    Drugs; 2005; 65(3):385-411. PubMed ID: 15669880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of colesevelam in patients with type 2 diabetes mellitus and inadequate glycemic control receiving insulin-based therapy.
    Goldberg RB; Fonseca VA; Truitt KE; Jones MR
    Arch Intern Med; 2008 Jul; 168(14):1531-40. PubMed ID: 18663165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes. UK Prospective Diabetes Study Group.
    Turner R; Stratton I; Horton V; Manley S; Zimmet P; Mackay IR; Shattock M; Bottazzo GF; Holman R
    Lancet; 1997 Nov; 350(9087):1288-93. PubMed ID: 9357409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.